Core Viewpoint - The article emphasizes the importance of integrating investments in physical infrastructure and human development to enhance overall economic and social progress in China, particularly in Chengdu [1]. Group 1: Investment in Physical Infrastructure - The 2025 Central Economic Work Conference highlighted the need for a close relationship between investments in physical assets and human capital [1]. - Chengdu is set to accelerate investments in key projects across various sectors, including advanced technology and cultural facilities, with significant projects like the completion of the Chengdu Grand Theatre and the approval of the "Electromagnetic Drive Fusion Large Scientific Device" [1]. - In 2026, Chengdu aims to enhance its industrial framework by adding 22 new provincial headquarters, which will account for 70% of the province's total [1]. Group 2: Investment in Human Development - Recent initiatives have extended benefits to critical areas such as healthcare, education, and elderly care, with reforms like "one registration covers three days" benefiting over 3.31 million patients and saving them more than 46.47 million yuan [2]. - The "three years to enter kindergarten" policy has allowed 1,660 children to enroll immediately upon reaching the appropriate age in 2025 [2]. - Chengdu plans to continue enhancing public cultural services and educational infrastructure, including the construction of 40 new schools and the addition of 58,000 new student places [2]. Group 3: Overall Development Strategy - The integration of investments in both physical and human aspects is seen as essential for achieving a high quality of life and economic growth, fostering a vibrant urban environment [3]. - The article suggests that a successful blend of industrial development and community engagement will lead to a more fulfilling urban experience, enhancing the city's competitiveness [3].

下一步，虽然涉事诊所证照齐全合规，但我局将依据《医疗纠纷预防和处理条例》对其进行全面深入调查，并依法依规处置到位。 据媒体此前报道，潘某的儿子韩先生介绍，53岁的母亲因上方牙齿松动决定去种牙。2025年12月17日，在两名家属的陪同下，她前往涉事口腔诊所就诊。 "我们知道母亲上面的牙需要处理，但我们不知道当天下午一次性把牙全部拔了。"韩先生说，母亲下巴脱臼合不上，整个人就感觉不行了。家属立马打了 120往县医院送。 近日，山西省曲沃县一名网友发帖称，舅妈去当地一家口腔诊所看牙，医生一次性把其上方12颗牙拔光，引发心梗、休克。 1月23日，曲沃县卫生健康局发布情况通报： 1月19日，我局接到患者家属关于曲沃德润口腔诊所有限公司福荣口腔诊所拔除患者潘某上颌部12颗牙齿导致牙床出血、休克、心梗的情况反映。经初步 调查认定，患者家属反映情况属实。目前，医患双方已就经济补偿达成和解，患者出院后居家休养。 长安街知事 ...

近日，第一财经记者独家了解到，有加拿大华人医生夫妇携幼女来到上海瑞金医院自费接受了一台高难 度的机器人胰腺肿瘤切除手术治疗，同时保住了女儿的脾脏，目前孩子已顺利康复出院。 他们没有选择在加拿大当地接受免费治疗的原因是被医生告知"这样的手术必须切除脾脏"。但中国医生 给出了一种两全的选项，不让患者做痛苦的"选择题"。 日前，十多位接受第一财经记者采访的专家一致认为，中国医疗远不止"性价比"，国内顶尖医疗技术的 发展水平已经不输全球发达国家，并且在一些先进技术应用方面的水平已经开始引领世界。发展国际医 疗业务对于国内医院、医生以及全球患者而言都是好事。 16万保脾还是"免费"切脾？ 在加拿大温哥华执业20年的华人Kevin医生夫妇近期带着10岁的女儿来到上海交通大学医学院附属瑞金 医院胰腺外科中心求医。在成功接受了高难度的机器人胰腺手术治疗后，目前孩子已经顺利康复出院。 花费16万元切除肿瘤保下脾脏，还是"免费"将肿瘤和脾脏同时切除？这个选择对有一定经济能力的人来 说并不难做。 Kevin在准备飞回温哥华的前一天与第一财经记者进行了一次面对面的交流。他告诉记者，女儿最近在 一次偶然的意外中被诊断出患有巨大胰腺实性 ...

Core Insights - In 2025, Beijing will launch the "Pingyuan New City Venture Capital Event" to connect investment institutions with over 300 projects in Pingyuan New City, addressing a financing demand of nearly 30 billion yuan [1][2] - Pingyuan New City is a crucial part of the Beijing-Tianjin-Hebei coordinated development strategy, encompassing Fangshan, Shunyi, Changping, Daxing, and Yizhuang, and aims to enhance regional collaboration and productivity [1] - The Beijing government plans to invest in over 400 fixed asset projects in Pingyuan New City, with significant infrastructure developments including the opening of the North Qing Road and Tongma Road, and the operational launch of Metro Line 18 [2] Investment and Development Plans - The Beijing Municipal Development and Reform Commission will implement a high-quality development plan for the five Pingyuan New Cities, establishing a special work mechanism for coordinated development [1] - An annual work plan will be created, detailing policies, tasks, and projects to ensure effective implementation, supported by a multi-dimensional evaluation system [1] - The initiative is expected to stimulate nearly 1,800 social investment projects, enhancing the overall capacity of the region [2] Industry-Specific Developments - Each Pingyuan New City is developing unique industries, such as the aviation engine maintenance project in Shunyi, the international pharmaceutical innovation park in Daxing Yizhuang, and the national-level testing platform for humanoid robots in Yizhuang [2] - Changping's Future Science City will see the delivery of its national laboratory core area, while Fangshan will implement new energy storage applications [2]

Investment Rating - The industry investment rating is maintained at "Overweight" [2] Core Insights - The report highlights that the pharmaceutical sector is showing resilience, with a focus on capturing opportunities from companies that can deliver on their growth potential. The report suggests that investors should continue to allocate to pharmaceutical bottom assets as fund holdings have returned to a low level [3][10] - The report indicates that the A-share funds' top ten holdings in the pharmaceutical sector account for 9.15%, a decrease of 1.93 percentage points from the previous period. Excluding pharmaceutical funds, the allocation drops to 3.43%, down 1.39 percentage points [3][10] - The report emphasizes the strong performance of certain pharmaceutical companies, particularly in innovative drugs and upstream life sciences, with notable profit growth forecasts for companies like Zhaoyan New Drug and Kangchen Pharmaceutical [3][10] Summary by Sections Market Dynamics - The pharmaceutical sector has outperformed the broader market, with a return of 6.66% compared to the CSI 300's 1.57% since the beginning of 2026, indicating a 5.10 percentage point advantage [14] - Recent performance shows a mixed trend, with pharmaceutical commercial, traditional Chinese medicine, and medical devices showing positive growth, while chemical pharmaceuticals and medical services have declined [10][14] Valuation Metrics - The current valuation of the pharmaceutical sector is at 23.3 times PE based on 2026 earnings forecasts, which is a premium of 11.3% compared to the overall A-share market (excluding financials) at approximately 21.0 times PE [17] - Using the TTM valuation method, the pharmaceutical sector is valued at 30.3 times PE, which is below its historical average of 34.9 times PE, indicating a relative premium of 11.2% over the broader market [17] Recommended Stocks - Key recommended stocks include WuXi Biologics, Sangfor Technologies, Tigermed, and others, with an average increase of 13.41% in January, outperforming the pharmaceutical sector by 6.74 percentage points [26][27] - The report notes that the top ten pharmaceutical stocks held by public funds include companies like Hengrui Medicine and WuXi AppTec, with a strong preference for innovative drugs and leading players in niche markets [3][10]

Core Viewpoint - The report from Industrial Securities emphasizes that the recent cooling in the market affects the rhythm and structure rather than the overall trend, with the core logic supporting the upward spring market remaining unchanged. The current spring market is still in progress, and although the market rhythm has slowed, the upward trend continues, with the profit effect expanding to a broader range [1]. Group 1: Liquidity and Catalysts - A liquidity-rich environment is the core driving force supporting the upward trend of the spring market, stemming from the strong performance of insurance funds and the influx of foreign capital due to the appreciation of the RMB [1][2]. - Insurance funds have shown impressive performance in the "opening red" period, with individual insurance premium growth rates exceeding 30% for leading companies, and some companies' individual insurance premiums surpassing 10 billion [1]. - The first half of this year is expected to see a peak in the maturity of residents' fixed deposits, creating an important window for residents to increase their allocation to equity assets [2]. - The continuous appreciation of the RMB is attracting foreign capital back to the market, with a record high of $99.9 billion in bank foreign exchange settlement surplus in December 2025, including a $11.5 billion surplus in securities investment [2]. Group 2: Market Structure and Performance - The current market is characterized by a warm macro environment and supportive policies, which are enhancing market risk appetite and driving the profit effect to expand across various sectors [3]. - The upcoming week will feature a concentrated window for industry catalysts, particularly with the earnings reports from North American tech giants, which may influence the domestic market [4]. - The earnings preview period is approaching its peak, with a disclosure rate expected to reach around 55%, which will significantly impact market structure [4][7]. Group 3: Earnings Forecasts and Sector Focus - As of January 23, 2025, 889 A-share listed companies have released earnings forecasts, with 304 companies expecting net profit growth exceeding 50%, primarily in sectors such as computing, chemicals, new energy, pharmaceuticals, and computer technology [5][6]. - The sectors with high growth or exceeding expectations in earnings forecasts include storage, new energy (battery storage, grid equipment), chemicals, and innovative pharmaceuticals [6][7]. - The report highlights that industries with low price increases during the current market rally include AI hardware, new energy, and various cyclical sectors [8]. Group 4: Future Market Outlook - February is anticipated to be a core window for bullish market activity, with a typical pattern of market volatility driven by liquidity and risk appetite, particularly in small-cap and growth sectors [9]. - The report suggests that themes such as AI applications, commercial space, and energy narratives should be revisited as they may gain renewed attention in February [9].

（编辑 丛可心） 证券日报网讯 1月25日，合富中国发布公告称，公司预计2025年年度归属于母公司所有者的净利润 为-3600万元到-2500万元，与上年同期相比将出现亏损；预计归属于母公司所有者的扣除非经常性损益 后的净利润为-3500万元到-2400万元。 ...

花费16万元切除肿瘤保下脾脏，还是"免费"将肿瘤和脾脏同时切除？这个选择对有一定经济能力的 人来说并不难做。 近日，第一财经记者独家了解到，有加拿大华人医生夫妇携幼女来到上海瑞金医院自费接受了一台高 难度的机器人胰腺肿瘤切除手术治疗，同时保住了女儿的脾脏，目前孩子已顺利康复出院。 他们没有选择在加拿大当地接受免费治疗的原因是被医生告知"这样的手术必须切除脾脏"。但中国医 生给出了一种两全的选项，不让患者做痛苦的"选择题"。 日前，十多位接受第一财经记者采访的专家一致认为，中国医疗远不止"性价比"，国内顶尖医疗技术 的发展水平已经不输全球发达国家，并且在一些先进技术应用方面的水平已经开始引领世界。发展国 际医疗业务对于国内医院、医生以及全球患者而言都是好事。 2026.01. 25 本文字数：5018，阅读时长大约8分钟 作者 | 第一财经 钱童心 16万保脾还是"免费"切脾？ 在加拿大温哥华执业20年的华人Kevin医生夫妇近期带着10岁的女儿来到上海交通大学医学院附属瑞 金医院胰腺外科中心求医。在成功接受了高难度的机器人胰腺手术治疗后，目前孩子已经顺利康复出 院。 Kevin在准备飞回温哥华的前一天与第一财 ...

2026年以来，地方产科业务调整消息不断。 例如，江西丰城矿务局总医院日前在公告中称，根据丰城市卫生健康委的工作部署，积极应对当前出生 率波动下降的人口发展新形势，进一步优化医疗资源，经医院研究决定，暂停开展孕产妇住院分娩业 务。 1月19日起，丰矿总医院妇产科住院部将正式停止接诊服务，妇产科相关门诊及诊疗服务如孕期产检等 将继续正常运行。 智通财经记者 钟煜豪 又一县域妇产科、儿科医疗资源实行整合优化。 日前，福建龙岩连城县妇幼保健院发布公告称，为优化县域医疗资源配置，提升妇女儿童医疗保健服务 能力，根据县委、县政府统一部署，连城县医院与连城县妇幼保健院妇产科、儿科、新生儿科医疗资源 将正式整合，成立连城县总医院妇儿医院（设于原连城县妇幼保健院内），并即将全面开诊。1月21日 起，连城县医院产科病房停止收治分娩孕妇，所有分娩相关医疗服务均由连城县妇幼保健院全面承接。 广东翁源县总医院也在1月23日宣布，根据中共翁源县委办公室、翁源县人民政府办公室印发的《翁源 县紧密型县域医疗卫生共同体建设改革方案》和县医管中心印发的《翁源县总医院改革工作方案》文件 精神，结合医院实际情况，为优化医疗资源配置，保障母婴医疗安 ...

中国医疗远不止"性价比"，国内顶尖医疗技术的发展水平已经不输全球发达国家，并且在一些先进技术应用方面的水平已经开始引领世界。 16万保脾还是"免费"切脾？ 在加拿大温哥华执业20年的华人Kevin医生夫妇近期带着10岁的女儿来到上海交通大学医学院附属瑞金医院胰腺外科中心求医。在成功接受了高难度的机器 人胰腺手术治疗后，目前孩子已经顺利康复出院。 Kevin在准备飞回温哥华的前一天与第一财经记者进行了一次面对面的交流。他告诉记者，女儿最近在一次偶然的意外中被诊断出患有巨大胰腺实性假乳头 状瘤的罕见疾病，这种疾病在欧美人群中的发病比较少见，很多医生都说没见过。 花费16万元切除肿瘤保下脾脏，还是"免费"将肿瘤和脾脏同时切除？这个选择对有一定经济能力的人来说并不难做。 近日，第一财经记者独家了解到，有加拿大华人医生夫妇携幼女来到上海瑞金医院自费接受了一台高难度的机器人胰腺肿瘤切除手术治疗，同时保住了女儿 的脾脏，目前孩子已顺利康复出院。 他们没有选择在加拿大当地接受免费治疗的原因是被医生告知"这样的手术必须切除脾脏"。但中国医生给出了一种两全的选项，不让患者做痛苦的"选择 题"。 日前，十多位接受第一财经记者采访的 ...